Report cover image

Middle East Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Product (Single Phase Products, Duplex Products), By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Country, And Segment Forecasts, 2025 - 20

Publisher Grand View Research
Published Aug 22, 2025
Length 175 Pages
SKU # GV20400263

Description

Market Size & Trends

The Middle East hyaluronic acid-based dermal fillers market size was estimated at USD 318.6 million in 2024 and is projected to reach USD 547.6 million by 2033, growing at a CAGR of 6.6% from 2025 to 2033. This growth is driven by the growing demand for non-invasive aesthetic treatment procedures and increasing awareness regarding hyaluronic acid (HA) application in the beauty segment. In the Middle East, demand for hyaluronic acid-based dermal fillers is driven by cultural, demographic, and economic factors. A strong emphasis on personal appearance and aesthetic enhancement, particularly in urban centers such as Dubai, Riyadh, and Qatar, has fueled interest in minimally invasive cosmetic procedures. Rising disposable incomes and expanding access to advanced aesthetic clinics have made these treatments more useful and widely available.

Hyaluronic acid (HA) based dermal fillers in the Middle East are experiencing steady growth in adoption, driven by rising patient interest in non-surgical aesthetic enhancements and an increasingly supportive regulatory environment. In January 2024, Abu Dhabi’s Department of Health introduced a Non-Surgical Cosmetics Standard that clearly defines training requirements, practitioner privileging, and mandatory adverse-event reporting for treatments such as HA fillers, with enforcement set to begin in 2025.

In Saudi Arabia, the Saudi Food and Drug Authority (SFDA) continues to regulate HA fillers as medical devices, requiring licensed administration and post-market safety monitoring measures that strengthen professional practice standards. Product availability is also expanding. For instance, in October 2024, the UAE Ministry of Health and Prevention approved two Neuramis HA fillers (“Deep Lidocaine” and “Volume Lidocaine”), widening the range of advanced options available to practitioners. Alongside regulatory and product developments, local clinical expertise is advancing-recent UAE-based multicenter research on HA for body contouring demonstrated high patient satisfaction and a favorable safety profile, reflecting the growing skill set of practitioners in the region’s aesthetic medicine sector.

Middle East Hyaluronic Acid-based Dermal Fillers Market Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East hyaluronic acid-based dermal fillers market report based on product, application, and country.
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Single Phase Products
  • Duplex Products
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Wrinkle Removal
  • Lip Augmentation
  • Rhinoplasty
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • Middle East
  • Turkey
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman
  • Rest of Middle East
Please note The report will be delivered in 4-8 business days upon order notification.

Table of Contents

175 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Application Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Middle East Hyaluronic Acid-Based Dermal Fillers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Middle East Hyaluronic Acid-Based Dermal Fillers Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Middle East Hyaluronic Acid-Based Dermal Fillers Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Middle East Hyaluronic Acid-Based Dermal Fillers Market Product Movement Analysis
4.3. Middle East Hyaluronic Acid-Based Dermal Fillers Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Single Phase Products
4.4.1. Single phase products market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Duplex Products
4.5.1. Duplex products market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Hyaluronic Acid-Based Dermal Fillers Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Middle East Hyaluronic Acid-Based Dermal Fillers Market Application Movement Analysis
5.3. Middle East Hyaluronic Acid-Based Dermal Fillers Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Wrinkle Removal
5.4.1. Wrinkle Removal market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Lip Augmentation
5.5.1. Lip Augmentation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Rhinoplasty
5.6.1. Rhinoplasty market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Hyaluronic Acid-Based Dermal Fillers Market: Country Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Middle East Hyaluronic Acid-Based Dermal Fillers Market movement analysis
6.3. Middle East Hyaluronic Acid-Based Dermal Fillers Market: Regional Estimates & Trend Analysis by Product & Application
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.4.1. Middle East
6.4.2. Middle East Hyaluronic Acid-Based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Qatar
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement scenario
6.4.3.5. Qatar Hyaluronic Acid-Based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Oman
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement scenario
6.4.4.5. Oman Hyaluronic Acid-Based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.5. Saudi Arabia
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Reimbursement scenario
6.4.5.5. Saudi Arabia Hyaluronic Acid-Based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.6. UAE
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Reimbursement scenario
6.4.6.5. UAE Hyaluronic Acid-Based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.7. Kuwait
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Reimbursement scenario
6.4.7.5. Kuwait Hyaluronic Acid-Based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.8. Turkey
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Reimbursement scenario
6.4.8.5. Turkey Hyaluronic Acid-Based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2024
7.4. Company Profiles/Listing
7.4.1. AbbVie, Inc.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Galderma
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Merz Pharma
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Genzyme Corporation
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Anika Therapeutics Inc.
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. LG Life Sciences
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Teoxane
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Sinclair
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. IBSA
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Jetema
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Prollenium
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us